{
    "symbol": "MOVE",
    "quarter": 1,
    "year": 2022,
    "date": "2022-05-15 02:49:05",
    "content": " But as you've heard in today's quarterly report, as well as through our commentary on previous quarterly calls, we're making great progress and doing so on a capital efficient basis as evidenced by today's news regarding the successful validation of the functionality of a proprietary and patented system on the chip, our plans for several more clinical studies in 2022 as we pursue a wide range of FDA clearances, and the build out of our go-to market team, which is positioning the company for a beta release of the Movano Ring in the back half of 2022 and a broader commercial launch following a successful beta program."
}